Prosecution Insights
Last updated: November 20, 2026

Jessica Marie Priest, USPTO Patent Examiner

Listed by the USPTO as PRIEST, JESSICA MARIE

Tech Center 1600 • Art Units: 1618 1642 1643

This examiner grants 0% of resolved cases

Performance Statistics

—
Allow Rate
-60.0% vs TC avg
19
Total Applications
—
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
15.8%
§102 Novelty
24.6%
§103 Obviousness
35.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18472160 METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION Non-Final OA REGENERON PHARMACEUTICALS, INC.
18404727 ANTI-FIBROTIC TISSUE RESIDENT MEMORY T CELLS AND USES THEREOF Non-Final OA THE JOHNS HOPKINS UNIVERSITY
18571614 Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins Non-Final OA AMGEN INC.
18580255 METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1 ANTAGONIST, AN ILT4 ANTAGONIST, AND CHEMOTHERAPEUTIC AGENTS Non-Final OA Merck Sharp & Dohme LLC
18711286 METHOD FOR THE TREATMENT OF PROGRESSIVE CHRONIC INTERSTITIAL LUNG DISEASE Non-Final OA UCB Biopharma SRL
18350637 IGM-MULTIMERIZED SINGLE-DOMAIN ANTIBODIES THAT BIND ROR1 Non-Final OA Fred Hutchinson Cancer Center

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

Which art unit does examiner Jessica Marie Priest work in?

Jessica Marie Priest examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month